Yuanyuan Sun

609 citations
28 papers · 479 indexed · h-index 14
Topics
Systemic Lupus Erythematosus Research (5 papers)Traditional Chinese Medicine Analysis (2 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Yuanyuan Sun

28 papers receiving 479 citations

Peers

Yuanyuan Sun
Comparison fields: 5 of 84
  • Molecular Biology 150
  • Immunology 104
  • Cancer Research 67
  • Oncology 63
  • Rheumatology 57
Replace Steven Dudics with:
Steven Dudics United States
Rongfen Huo China
Zhongzheng Lu China
Mojgan Noroozi Karimabad Iran
Barbara Strzałka‐Mrozik Poland
Vibha Singh India
Carolina Heitmann Mares Azevedo Brazil
Atıl Bişgin Türkiye
Yuka Sasakawa Japan
Yuanyuan Sun relative to Steven Dudics United States Steven Dudics's profile →
Citations per field
00.5×
Steven Dudics · 1×
Citations per year

Countries citing papers authored by Yuanyuan Sun

Since Specialization
Citations

This map shows the geographic impact of Yuanyuan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Sun more than expected).

Fields of papers citing papers by Yuanyuan Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyuan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Sun. The network helps show where Yuanyuan Sun may publish in the future.

Co-authorship network of co-authors of Yuanyuan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyuan Sun. A scholar is included among the top collaborators of Yuanyuan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyuan Sun. Yuanyuan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 1
4 8
5 35
6 13
7 13
8 31
9 8
10 13
11 24
12 26
13 22
14 5
15 35
16 11
17 57
18 39
19 25
20 3

About Yuanyuan Sun

Yuanyuan Sun is a scholar working on Rheumatology, Hematology and Complementary and alternative medicine, having authored 28 papers that have together received 479 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (5 papers), Traditional Chinese Medicine Analysis (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). The work is most often cited by research in Immunology (104 citations), Hematology (51 citations) and Cancer Research (67 citations). Yuanyuan Sun has collaborated with scholars based in China and United States. Frequent co-authors include Jing Pan, Xinghua Xu, Dadong Guo, Hongsheng Bi, Dong Wang, Huixia Wei, Xin Wei, Zhenshan Jia, Steven R. Goldring and Subodh M. Lele. Their work appears in journals such as PLoS ONE, Journal of Controlled Release and Journal of Environmental Management.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026